Comparing two screening tests for early cervical changes and cervical cancer
Compares a molecular screening test with a Pap smear in women.
Plain-language title generated from the registry record
Registry title: Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
Key facts
- Where
- Mexico City, MexicoSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT07480902, who can take part
Where in Mexico
- Consultorio Médico TIMSERMexico City, MexicoTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Timser SAPI de CV
- Trial code
- NCT07480902
- Record updated
- 18 March 2026
- Original description
This study compares how effective is the molecular screening (a blood test) using Pap smear as reference, that is, a comparison of these tests abilities to detect precursor lesions and cervical cancer among women of an open populationRead full original descriptionShow less
Study To Compare The Efficacy Of Cervical Cytology With Molecular Screening For Detecting Reactive Cellular Changes In The Cervix In An Open Population
This study compares how effective is the molecular screening (a blood test) using Pap smear as reference, that is, a comparison of these tests abilities to detect precursor lesions and cervical cancer among women of an open population
Inclusion: Be in good general health; Age 18-85 years; A minimum fast of 6 hours and no more than 12 hours; Refrain from sexual intercourse 24 hours before the study; Give written informed consent.
Exclusion: Being under oncological treatment (chemotherapy, radiotherapy and/or brachytherapy); Have a previous confirmatory diagnosis of HIV and/or hepatitis infection; Having taken antiplatelet medications, e.g., acetylsalicylic acid, at least 24 hours before the study; Discontinuation Criteria:; Having a subtotal, total, or radical hysterectomy; Being pregnant or suspected of being pregnant. A rapid urine test will be performed. If the result is positive, the patient will be excluded from the protocol and referred for prenatal care; Being on their period; If the participant refuses any of the study procedures; If the study gynecologist detects that the participant has had a hysterectomy; If the volume of the biological samples is insufficient for testing.